Harnessing Peptide-Major Histocompatibility Complex- Based Nanomedicines to Treat Autoimmunity by Expanding Antigen-Specific Tregs In Vivo
Time: 1:30 pm
day: Day 1 Treg Modulatorstrack
Details:
- Analyzing nanomedicines as effective triggers of endogenous Treg generation to modulate immunoregulation
- Describing the mechanisms of action involved in the pMHC nanomedicine platform to generate disease specific Tregs
- Exploring applications of pMHC nanomedicines in Liver autoimmunity, T1D and MS
